Genetic variation in stromal proteins decorin and lumican with breast cancer: investigations in two case-control studies
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1465-542X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Genetic variation in stromal proteins decorin and lumican with breast cancer: investigations in two case-control studies ; volume:10 ; number:6 ; day:26 ; month:11 ; year:2008 ; pages:1-11 ; date:12.2008
Breast cancer research ; 10, Heft 6 (26.11.2008), 1-11, 12.2008
- Urheber
-
Kelemen, Linda E.
- Beteiligte Personen und Organisationen
-
Couch, Fergus J.
Ahmed, Shahana
Dunning, Alison M.
Pharoah, Paul DP
Easton, Douglas F.
Fredericksen, Zachary S.
Vierkant, Robert A.
Pankratz, V Shane
Goode, Ellen L.
Scott, Christopher G.
Rider, David N.
Wang, Xianshu
Cerhan, James R.
Vachon, Celine M.
SpringerLink (Online service)
- DOI
-
10.1186/bcr2201
- URN
-
urn:nbn:de:1111-201603241958
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:47 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kelemen, Linda E.
- Couch, Fergus J.
- Ahmed, Shahana
- Dunning, Alison M.
- Pharoah, Paul DP
- Easton, Douglas F.
- Fredericksen, Zachary S.
- Vierkant, Robert A.
- Pankratz, V Shane
- Goode, Ellen L.
- Scott, Christopher G.
- Rider, David N.
- Wang, Xianshu
- Cerhan, James R.
- Vachon, Celine M.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Clinical software development for the Web: lessons learned from the BOADICEA project
Susceptibility gene mutations in germline and tumors of patients with HER2-negative advanced breast cancer
The admixture maximum likelihood test to test for association between rare variants and disease phenotypes
BRCA-mutated breast cancer: the unmet need, challenges and therapeutic benefits of genetic testing
Incorporating tumour pathology information into breast cancer risk prediction algorithms
Letter to the editor: a response to Ming’s study on machine learning techniques for personalized breast cancer risk prediction
BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families
Cancer incidence in relatives of British Fanconi Anaemia patients
The PALB2 p.Leu939Trp mutation is not associated with breast cancer risk
Common ERBB2 polymorphisms and risk of breast cancer in a white British population: a case–control study
Common variation in EMSYand risk of breast and ovarian cancer: a case-control study using HapMap tagging SNPs
BRCA1 and BRCA2 mutations in a population-based study of male breast cancer
Clinical software development for the Web: lessons learned from the BOADICEA project
Susceptibility gene mutations in germline and tumors of patients with HER2-negative advanced breast cancer
The admixture maximum likelihood test to test for association between rare variants and disease phenotypes
BRCA-mutated breast cancer: the unmet need, challenges and therapeutic benefits of genetic testing
Incorporating tumour pathology information into breast cancer risk prediction algorithms
Letter to the editor: a response to Ming’s study on machine learning techniques for personalized breast cancer risk prediction
BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families
Cancer incidence in relatives of British Fanconi Anaemia patients
The PALB2 p.Leu939Trp mutation is not associated with breast cancer risk
Common ERBB2 polymorphisms and risk of breast cancer in a white British population: a case–control study
Common variation in EMSYand risk of breast and ovarian cancer: a case-control study using HapMap tagging SNPs
BRCA1 and BRCA2 mutations in a population-based study of male breast cancer
Clinical software development for the Web: lessons learned from the BOADICEA project
Susceptibility gene mutations in germline and tumors of patients with HER2-negative advanced breast cancer
The admixture maximum likelihood test to test for association between rare variants and disease phenotypes
BRCA-mutated breast cancer: the unmet need, challenges and therapeutic benefits of genetic testing
Incorporating tumour pathology information into breast cancer risk prediction algorithms
Letter to the editor: a response to Ming’s study on machine learning techniques for personalized breast cancer risk prediction
BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families
Cancer incidence in relatives of British Fanconi Anaemia patients
The PALB2 p.Leu939Trp mutation is not associated with breast cancer risk
Common ERBB2 polymorphisms and risk of breast cancer in a white British population: a case–control study
Common variation in EMSYand risk of breast and ovarian cancer: a case-control study using HapMap tagging SNPs